5.79 USD
↗ 0.05 (0.87%)AT CLOSE (11:59 AM EDT)
Clene Inc. Common Stock
CLNNNASDAQ • USD
5.76
↘ 0.03 (0.45%)
POST MARKET (AS OF 06:48 PM EDT)
Post Market
AS OF 06:48 PM EDT
5.76
↘ 0.03 (0.45%)
Market: CLOSED
Shares of Clene Inc. Common Stock (CLNN) are trading at $5.77. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (177.9%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 25, 2026.
Open?$5.65
High?$6.08
Low?$5.60
Prev. Close?$5.74
Volume?106.1K
Avg. Volume?128.9K
VWAP?$5.80
Rel. Volume?0.82x
Bid / Ask
Bid?$5.73 × 1.0K
Ask?$5.93 × 4.0K
Spread?$0.20
Midpoint?$5.83
Valuation & Ratios
Market Cap?73.3M
Shares Out?12.8M
Float?8.3M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-3.90
EPS?-$2.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Themes
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?3
Short Sent.?39
Piotroski F-Score?2/9Weak
Altman Z-Score?-22.21Distress
Confidence?62%Moderate
Short InterestVery High
Short % of Float?12.76%High
Short Interest?1.1M
Days to Cover?10.3
Free Float8.3M
Avg Daily Volume102.1K
Settlement Date2026-06-15
Financial Health
Current Ratio?1.94Adequate
Quick Ratio?1.93Adequate
Cash Ratio?0.88Adequate
Debt/Equity?-0.97Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-3.90CHEAP▾
S&P97
P/S?547.37HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.4CHEAP▾
S&P97
EV/Sales?638.91HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?177.9%STRONG▾
Peers50
S&P97
ROA?-154.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-18102000
Enterprise Value?$85.6M
Fundamentals ratios updated end of day